SARAH ANDERSON: Open Payments
NPI 1821561077 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 8 payments from 7 companies in 2025. Trend: 2023 $4,595 · 2024 $2,542 · 2025 $840
Food & beverage: $741Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $227 |
| GENZYME CORPORATION | 1 | $145 |
| Organon LLC | 1 | $141 |
| ABBVIE INC. | 1 | $129 |
| Janssen Biotech, Inc. | 1 | $99 |
| Lilly USA, LLC | 1 | $72 |
| Amgen Inc. | 1 | $27 |
Products named: DUPIXENT, VTAMA, SKYRIZI, TREMFYA, COSENTYX, TALTZ, OTEZLA.
Industry payments across IL — which companies pay providers there.
